Sentences with phrase «neuroendocrine tumor patients»

This data warrants further testing of the long - term cardioprotective benefit of an mTORKi in neuroendocrine tumor patients prone to carcinoid syndrome.

Not exact matches

Finding new treatments is critical because less than 5 percent of patients with pancreatic neuroendocrine tumors respond to everolimus, the most commonly used pharmaceutical, François said.

Patients with aggressive neuroendocrine tumors (NETs) have limited treatment options and there are few oncologists who are specialised in this relatively rare disease.

Researchers at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) are presenting a molecular imaging technique that allows oncologists to set patients» radiotherapy doses right at that critical limit of delivering the most powerful kill to neuroendocrine tumors (NETs) while protecting vulnerable vital organs.

«Molecular imaging of neuroendocrine tumors optimizes radiotherapy dose: Study shows the use of PET and SPECT tailors radionuclide treatment for neuroendocrine cancer patients and reduces the risk of toxicity.»

In 2011, based on initial findings from two clinical trials, the Food and Drug Administration approved sunitinib and everolimus for patients with pancreatic neuroendocrine tumors.

In the first set of experiments, the Johns Hopkins scientists sequenced nearly all protein - encoding genes in 10 of the 68 samples of pancreatic neuroendocrine tumors and compared these sequences with normal DNA from each patient to identify tumor - specific changes or mutations.